Literature DB >> 412877

A double-blind comparison of meptazinol with pentazocine and placebo in cancer pain.

M Staquet.   

Abstract

Two consecutive double-blind, crossover, single-administration trials have shown that intramuscular meptazinol, a new opioid-antagonist drug, is superior to placebo and equivalent ot pentazocine in relieving chronic pain due to cancer.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 412877     DOI： 10.1002/j.1552-4604.1978.tb01563.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


  4 in total

1.  [Not Available].

Authors:  J Radke; E Turner; D Kettler
Journal:  Schmerz       Date:  1990-12       Impact factor: 1.107

Review 2.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Effects of graded oral doses of meptazinol and pentazocine in comparison with placebo on experimentally induced pain in healthy humans.

Authors:  G Stacher; H Steinringer; S Winklehner; G Mittelbach; C Schneider
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

Review 4.  Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B Holmes; A Ward
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.